Learn more

JIANGXI QINGFENG PHARMACEUTICAL CO LTD

Overview
  • Total Patents
    67
  • GoodIP Patent Rank
    61,961
  • Filing trend
    ⇩ 62.0%
About

JIANGXI QINGFENG PHARMACEUTICAL CO LTD has a total of 67 patent applications. It decreased the IP activity by 62.0%. Its first patent ever was published in 2010. It filed its patents most often in China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and measurement are CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTD, BEIJING JIMEITANG MEDICINE RES CO LTD and CLINO LTD.

Patent filings in countries

World map showing JIANGXI QINGFENG PHARMACEUTICAL CO LTDs patent filings in countries

Patent filings per year

Chart showing JIANGXI QINGFENG PHARMACEUTICAL CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Yang Xiaoling 38
#2 Liu Difa 32
#3 Li Zhiyong 30
#4 Xie Ning 27
#5 Cheng Fan 25
#6 Liu Yaoqi 20
#7 Lv Wuqing 20
#8 Tang Chunshan 20
#9 Wang Zhangwei 16
#10 Tang Xinqian 13

Latest patents

Publication Filing date Title
CN111662246A Mirabegron impurity compound and preparation method and application thereof
CN111518152A Preparation method and application of 3 alpha, 7 alpha-dihydroxy-6 alpha-ethyl-5 beta-cholane-24-aldehyde
CN111333633A Rugosril intermediate compound and preparation method and application thereof
CN111423452A Rugoside intermediate, preparation method and application thereof
CN111303234A Abiraterone acetate monocrystal and preparation method thereof
CN111320552A Preparation method of enzalutamide intermediate
CN111253461A Synthesis method of 7-oxoacetic acid abiraterone
CN109535107A One kind (R) -4- propyl-dihydrofuran -2- ketone preparation method
CN109574778A A kind of preparation method of Bu Waxitan and its intermediate
CN109613174A A kind of detection method of quassia total alkaloid content
CN107973764A Andrographolide class compound, its preparation method, pharmaceutical composition and application
CN107648245A Application of the neohesperidin in prevention and treatment senile dementia is prepared
CN107693530A Aurantiamarin and/or aurantiin are preparing the application in improving cognition dysfunction medicine
CN107569477A The new application of ethyl sulfuric acid class compound
CN109394746A Ethyl sulfuric acid ammonium is in preparation for preventing or treating the application in diseases associated with inflammation drug
CN109381453A Potassium ethyl sulfate is in preparation for preventing or treating the application in diseases associated with inflammation drug
CN109381452A Application of ethyl sulfuric acid class compound and preparation method thereof
CN108392478A Application of the andrographolide class compound in terms of preparing for radioactive damage drug
CN107375271A Application of the andrographolide sulfonate/derivative/mixture in treatment/prevention of neurodegenerative diseases medicine is prepared
CN107375272A Application of the Camptotheca acuminata leaves in treatment and/or prevention of neurodegenerative diseases medicine is prepared